[Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E, F López Rois, Vázquez Carrete Ja, Gómez Tato B, Alvarez Ares M
Abstract
Vázquez Fernández E, F López Rois, Vázquez Carrete Ja, Gómez Tato B, Alvarez Ares M
Abstract
Vaccine coverage, morbidity prevalence, and immunity to measles, rubella, and mumps, were estimated in 1985-1986 among a sample of 2 to 5 years old Galician children, studied through questionnaires and immunoenzymatic determinations of antibodies. According to the mothers, measles vaccine and measles-mumps-rubella vaccine were administered to 22.1% and 45.7%, respectively, of their children, whereas measles were reported in 17.9, mumps in 14.3%, and rubella in 2.9%. The seroconversion to rubella (50.7%) resulted significantly lower (p less than 0.001) than that to measles (75%) or mumps (68.6%). The three types of antibodies were found altogether in 32.1% of the subjects, and 5% of them showed none of these antibodies. The analysis of the serologic data stresses the need for reaching rapidly higher vaccination rates.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Vaccine coverage, morbidity prevalence, and immunity to measles, rubella, and mumps, were estimated in 1985-1986 among a sample of 2 to 5 years old Galician children, studied through questionnaires and immunoenzymatic determinations of antibodies. According to the mothers, measles vaccine and measles-mumps-rubella vaccine were administered to 22.1% and 45.7%, respectively, of their children, whereas measles were reported in 17.9, mumps in 14.3%, and rubella in 2.9%. The seroconversion to rubella (50.7%) resulted significantly lower (p less than 0.001) than that to measles (75%) or mumps (68.6%). The three types of antibodies were found altogether in 32.1% of the subjects, and 5% of them showed none of these antibodies. The analysis of the serologic data stresses the need for reaching rapidly higher vaccination rates.
Key concepts: Medicine, Measles, Rubella, Seroconversion, Vaccination, MMR vaccine, Measles-Mumps-Rubella Vaccine, Population